Skip to main content

levonorgestrel (Isteranda®)

 

Status: Medicine does not meet criteria for AWMSG assessment

Excluded from appraisal by AWMSG as meets exclusion criteria 7. See AWMSG criteria for appraising a medicine (PDF, 430Kb) for information.

Medicine details

Medicine name levonorgestrel (Isteranda®)
Formulation 1.5 mg tablet
Reference number 2598
Indication

Emergency contraception within 72 hours of unprotected sexual intercourse or failure of a contraception method

Company Sandoz Ltd
BNF chapter Obstetrics, gynaecology & urinary tract disorders
Assessment type N/A
Status Medicine does not meet criteria for AWMSG assessment
Date of issue 19/02/2015
Follow AWTTC: